Former President Donald Trump has boasted in recent months about "Right To Try," a law he signed in 2018. It's aimed at ...

S4V2 will be tested for safety and preliminary efficacy in approximately 120 healthy Shigella -naïve participants aged 18 to 50 years at three sites in the United States. The study, sponsored and ...

There are several ways Trump could further limit abortion access without breaking his campaign promise not to implement a national ban, experts said.

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA ...

In August, a district judge dismissed GenBioPro’s case, ruling that West Virginia’s law supersedes the Food and Drug Administration’s approval of the drug. The case was appealed to the U.S. Court of ...

Queens and Staten Island merged with New York City. The Bronx Zoo opened. The inventor of basketball, Dr. James Naismith, was ...

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% ...

The Centers for Disease Control and Prevention typically coordinates between 17 and 36 investigations of foodborne illnesses involving multiple states each week. A report is posted weekly, but ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the pivotal Phase 3 study design following successful alignment with the U.S. Food and Drug Administration (FDA) on ION582, an ...

In most states, Medicaid — the largest payer of substance use disorder treatment in the U.S. — caps the doses it will pay for at arbitrary levels, typically at no more than 24 milligrams.